United Capital Financial Advisers, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

United Capital Financial Advisers, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$62.15 - $90.32 $392,539 - $570,461	-6,316 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$61.35 - $90.47 $17,791 - $26,236	-290 Reduced 4.39%	6,316 $419,000
Q4 2020 Feb 17, 2021	SELL	$43.82 - $85.37 $13,146 - $25,611	-300 Reduced 4.34%	6,606 $507,000
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $19,062 - $29,428	-574 Reduced 7.67%	6,906 $297,000
Q2 2020 Aug 13, 2020	SELL	$26.12 - $43.27 $6,373 - $10,557	-244 Reduced 3.16%	7,480 $323,000

Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $54,381 - $166,952	2,645 Added 52.08%	7,724 $222,000
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $142,923 - $370,817	5,079 New	5,079 $322,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on United Capital Financial Advisers, LLC with notifications on news.